Navigation Links
Silence Therapeutics and InteRNA Technologies Sign Collaboration to Develop Novel microRNA Therapeutics
Date:9/11/2011

ultiple proprietary siRNA delivery technology platforms including AtuPLEX™ and DACC. AtuPLEX enables the broad functional delivery of siRNA molecules to targeted diseased tissues and cells, while increasing their bioavailability and intracellular uptake. The DACC delivery system allows functional delivery of siRNA molecules selectively to the lung endothelium with a long duration of target mRNA and protein knock-down. Additionally, the Company has a platform of novel siRNA molecules based around its AtuRNAi chemical modification technology, which provides a number of advantages over conventional siRNA molecules. Silence's unique RNAi assets also include structural features for RNAi molecules and specific design rules for increased potency and reduced off-target effects of siRNA sequences.

The Company's lead internal drug candidate is Atu027, a liposomal formulation in clinical development for systemic cancer indications and one of the most clinically advanced RNAi therapeutic candidates in the area of oncology. Atu027 incorporates two of the Company's technologies, AtuRNAi and AtuPLEX™. Silence is currently conducting an open-label, single-centre, dose-escalation Phase I study with Atu027 in patients with advanced solid tumors involving single, as well as repeated, intravenous administration. Encouraging interim data were presented at the American Society of Clinical Oncology Annual Meeting in June 2011. The study is expected to be completed in the second half of 2011.

The Company's RNAi therapeutic platform has received key validation through multiple partnerships with pharmaceutical companies including AstraZeneca, Dainippon Sumitomo, Pfizer/Quark, and Novartis/Quark. Silence is actively pursuing the establishment of additional partnerships. Silence Therapeutics has operations in both Berlin and London.

About InteRNA Technologies B.V. (http://www.interna-technologies.com'/>"/>

SOURCE Silence Therapeutics Plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology
2. Silence Therapeutics Phase I Atu027 Data Accepted for Presentation at the American Society of Clinical Oncology 2011 Annual Meeting
3. Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials
4. Silence Therapeutics Provides Year-end Update
5. Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics
6. Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration
7. Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
8. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
9. Silence Therapeutics Announces Board Changes
10. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
11. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , August 29, 2014 ... Market by Product & Services (Equipment, Reagent, Primer, ... Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, ... MarketsandMarkets, the global Oligonucleotide Synthesis Market is expected ... Million in 2014, growing at a CAGR of ...
(Date:8/29/2014)... Aug. 29, 2014  In part four ... a hospital pharmacy as a strategic asset, Mary ... leader for Cardinal Health,s Innovation Delivery Solutions business, discusses ... benefit both hospitals and patients. "Every hospital ... part of their job in a value-based healthcare world," ...
(Date:8/29/2014)... -- Research and Markets  has announced the addition ... Market 2014-2018" report to their offering. ... that connect, support, or surround bones. There are several ... cartilage, fascia, and other fibrous tissues. Repetitive use, accidents, ... result in wear and tear in these tissues. Orthopedic ...
Breaking Medicine Technology:Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3
... RALEIGH, N.C., Sept. 6, 2011 BioDelivery Sciences ... positive preliminary results from its Phase 1 study ...  BDSI is seeking to develop and commercialize a ... (abuse deterrent agent) for the treatment of opioid ...
... NEW YORK, Sept. 6, 2011 ... new market research report is ... Emerging Pharmaceutical Market ... Between Domestic and International Pharmaceutical ...
Cached Medicine Technology:BioDelivery Sciences Announces Positive Results Supporting BEMA Buprenorphine/Naloxone Formulation for Opioid Dependence 2BioDelivery Sciences Announces Positive Results Supporting BEMA Buprenorphine/Naloxone Formulation for Opioid Dependence 3BioDelivery Sciences Announces Positive Results Supporting BEMA Buprenorphine/Naloxone Formulation for Opioid Dependence 4Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 2Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 3Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 4Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 5Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 6Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 7Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 8Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 9Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 10Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 11
(Date:8/29/2014)... According to this latest review published by DailyGossop.org, this is ... it is amazingly effective. In fact, the program is commonly ... , Driver Robot is so popular, as it can ... highly effective in finding the right drivers that users need ... writes in its Driver Robot review that what users need ...
(Date:8/29/2014)... August 29, 2014 Cosmetic Town has ... and authenticity of its doctors. Cosmetic Town utilizes ... most renowned doctors in their field are chosen to ... patients have a direct link to potentially hundreds of ... will be able to communicate through the site’s community ...
(Date:8/29/2014)... Denver, CO (PRWEB) August 29, 2014 ... panic attack is the feeling of intense stress and ... entire life of the sufferer, causing insecurity and affecting ... numerous factors and there are many symptoms that patients ... stress are among these symptoms. Overcoming panic attacks is ...
(Date:8/29/2014)... Denver, Colorado (PRWEB) August 29, 2014 Daily ... was created by someone who can perfectly understand what patients ... , Eric Bakker is the creator of this new ... candida infection patients throughout the years. , Bakker claims ... coming from patients, saying how difficult living with the yeast ...
(Date:8/29/2014)... Developed as a nod to post-war ... Canada Goose products offer the mobility, durability and ... runways. The company’s Canada Goose Chilliwack bombers ... market. Additionally, the firm has unveiled its new bomber ... At present, all high quality Chilliwack bombers are provided ...
Breaking Medicine News(10 mins):Health News:Driver Robot Review Exposes Popular Hardware Detection Tool 2Health News:Cosmetic Town Now Advocates for the Rights of Cosmetic Patients Using Novel Approach 2Health News:60 Second Panic Solution Review Exposes Simple Panic Attacks Remedy 2Health News:Candida Crusher Review Reveals a Unique Way to Eliminate Yeast Infection Permanently 2Health News:New Designs Of Canada Goose Chilliwack Bombers From DoudouneCanadienneGoosePasCher.fr 2
... Consensus Guideline Reached For Quantitative Polymerase Chain ReactionSALT LAKE ... and the American Association for Clinical ... guideline for a key laboratory method called qPCR (or ... of international scientists representing the medical and research fields. ...
... AdCare Health Systems, Inc. (NYSE AMEX: ADK ... and management company today reported financial results for its ... December 31, 2008 were $24,793,294 as compared to $23,667,756 ... The improvement was primarily due to increased rental charges ...
... alerting capabilities, delivering meaningful performance measurements and relevant operational data ... ... Plano, TX (PRWEB) March 31, 2009 -- ... - Corepoint Decisions . Corepoint Health,s latest product ...
... 31 Hanger Orthopedic Group, Inc. (NYSE: HGR ) ... operations for the first quarter ended March 31, 2009, on ... release announcing the results for the first quarter ended March ... of the market. The conference call is scheduled to begin ...
... provider of advanced, high-volume, document and payment processing ... signed an exclusive service provider agreement with iVu ... early detection of cancer and other disease states. ... BancTec,s growing Multi-Vendor Services Group."BancTec,s Multi-Vendor Services Group ...
... League biologist who researches viruses to determine how and why ... of Houston April 2. The lecture is free and ... University associate professor of ecology and evolutionary biology, will speak ... the Science and Engineering Classroom Building Auditorium. His talk ...
Cached Medicine News:Health News:International Scientists Secure Quality in Molecular Diagnostics 2Health News:International Scientists Secure Quality in Molecular Diagnostics 3Health News:AdCare Health Systems, Inc. Reports Financial Results for 2008 2Health News:AdCare Health Systems, Inc. Reports Financial Results for 2008 3Health News:AdCare Health Systems, Inc. Reports Financial Results for 2008 4Health News:AdCare Health Systems, Inc. Reports Financial Results for 2008 5Health News:AdCare Health Systems, Inc. Reports Financial Results for 2008 6Health News:AdCare Health Systems, Inc. Reports Financial Results for 2008 7Health News:AdCare Health Systems, Inc. Reports Financial Results for 2008 8Health News:AdCare Health Systems, Inc. Reports Financial Results for 2008 9Health News:Corepoint Health Launches New Product Suite Focused on Enhancing Healthcare Operations & Metrics 2Health News:Corepoint Health Launches New Product Suite Focused on Enhancing Healthcare Operations & Metrics 3Health News:Corepoint Health Launches New Product Suite Focused on Enhancing Healthcare Operations & Metrics 4Health News:Hanger Orthopedic Group, Inc. Announces First Quarter 2009 Earnings Release Conference Call 2Health News:iVu Imaging Selects BancTec's Multi-Vendor Services Group as Exclusive Service Provider for Intelligent Volumetric Ultrasound Equipment 2Health News:iVu Imaging Selects BancTec's Multi-Vendor Services Group as Exclusive Service Provider for Intelligent Volumetric Ultrasound Equipment 3Health News:Virus evolution topic of Darwin talk at UH April 2 2
Coude Foley Catheters (Latex) 2-Way Amber...
Silicone Elastomer-Coated Latex Foley Catheters 3-Way...
Silicone Foley Catheters 3-Way...
Midstream Catch Kits...
Medicine Products: